SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-001641
Filing Date
2023-01-05
Accepted
2023-01-04 18:13:04
Documents
3
Group Members
GNI HONG KONG LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D d440424dsc13d.htm SC 13D 74878
2 EX-99.A d440424dex99a.htm EX-99.A 5204
3 EX-99.B d440424dex99b.htm EX-99.B 6490
  Complete submission text file 0001193125-23-001641.txt   88174
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82442 | Film No.: 23508711
SIC: 2834 Pharmaceutical Preparations

Mailing Address NIHONBASHI-HONCHO YS BLDG 3F 2-2-2 NIHONBASHI-HONCHO, CHUO-KU TOKYO M0 103-0023
Business Address NIHONBASHI-HONCHO YS BLDG 3F 2-2-2 NIHONBASHI-HONCHO, CHUO-KU TOKYO M0 103-0023 81-3-6214-3600
GNI Group Ltd. (Filed by) CIK: 0001958461 (see all company filings)

IRS No.: 000000000
Type: SC 13D